Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCapital Advantage, Inc.
Latest Disclosed Ownership2,914 shares
Latest Disclosed Value $ 1,025,464
Capital Advantage, Inc. reports 1.39% decrease in ownership of AMGN / Amgen Inc.

On April 10, 2026 - Capital Advantage, Inc. filed a 13F-HR form disclosing ownership of 2,914 shares of Amgen Inc. (MX:AMGN) valued at $1,025,464 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 2,955 shares of Amgen Inc.. This represents a change in shares of -1.39% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F AMGEN COM 031162100 2,914 -41 -1.39 1,025 6.00 0.1341
2026-01-07 2025-12-31 13F AMGEN COM 031162100 2,955 -74 -2.44 967 13.23 0.1305
2025-10-22 2025-09-30 13F AMGEN COM 031162100 3,029 -18 -0.59 855 0.47 0.1286
2025-07-11 2025-06-30 13F AMGEN COM 031162100 3,047 -47 -1.52 851 5.46 0.1347
2025-04-10 2025-03-31 13F AMGEN COM 031162100 3,094 0 0.00 806 0.00 0.1469
2025-02-14 2024-12-31 13F AMGEN COM 031162100 3,094 3,094 806 0.1469
2021-08-16 2021-06-30 13F Amgen Com 031162100 0 -2,963 -100.00 0 -100.00
2021-04-26 2021-03-31 13F Amgen Com 031162100 2,963 282 10.52 737 20.62 0.2009
2021-02-17 2020-12-31 13F Amgen COM 031162100 2,681 141 5.55 611 -6.72 0.1821
2020-11-12 2020-09-30 13F Amgen COM 031162100 2,540 -49 -1.89 655 7.20 0.2156
2020-08-13 2020-06-30 13F Amgen COM 031162100 2,589 62 2.45 611 2.86 0.2170
2020-05-08 2020-03-31 13F Amgen COM 031162100 2,527 118 4.90 594 9.39 0.2320
2020-02-14 2019-12-31 13F Amgen COM 031162100 2,409 -139 -5.46 543 10.14 0.1717
2019-11-12 2019-09-30 13F Amgen COM 031162100 2,548 461 22.09 493 24.49 0.1707
2019-05-10 2019-03-31 13F Amgen COM 031162100 2,087 87 4.35 396 1.80 0.1406
2019-02-07 2018-12-31 13F Amgen COM 031162100 2,000 8 0.40 389 -5.81 0.1475
2018-11-01 2018-09-30 13F Amgen COM 031162100 1,992 -59 -2.88 413 8.97 0.0949
2018-08-01 2018-06-30 13F Amgen COM 031162100 2,051 -46 -2.19 379 6.16 0.0893
2018-05-02 2018-03-31 13F Amgen COM 031162100 2,097 27 1.30 357 -0.83 0.0873
2018-02-13 2017-12-31 13F Amgen COM 031162100 2,070 -77 -3.59 360 -10.00 0.0928
2017-10-30 2017-09-30 13F Amgen COM 031162100 2,147 11 0.51 400 8.70 0.1001
2017-08-08 2017-06-30 13F Amgen COM 031162100 2,136 3 0.14 368 5.14 0.0964
2017-05-03 2017-03-31 13F Amgen COM 031162100 2,133 122 6.07 350 19.05 0.0959
2017-02-01 2016-12-31 13F Amgen COM 031162100 2,011 129 6.85 294 -6.37 0.0852
2016-11-02 2016-09-30 13F Amgen COM 031162100 1,882 2 0.11 314 9.79 0.0881
2016-08-10 2016-06-30 13F Amgen COM 031162100 1,880 -379 -16.78 286 -15.63 0.0831
2016-05-23 2016-03-31 13F Amgen COM 031162100 2,259 36 1.62 339 -6.09 0.1202
2016-02-26 2015-12-31 13F Amgen COM 031162100 2,223 244 12.33 361 31.75 0.1217
2015-10-23 2015-09-30 13F Amgen COM 031162100 1,979 -78 -3.79 274 -13.29 0.1068
2015-08-14 2015-06-30 13F Amgen COM 031162100 2,057 1 0.05 316 -3.95 0.1232
2015-05-15 2015-03-31 13F Amgen COM 031162100 2,056 1 0.05 329 0.61 0.1350
2015-05-15 2014-12-31 13F Amgen COM 031162100 2,055 1 0.05 327 13.54 0.1348
2016-06-21 2014-09-30 13F Amgen COM 031162100 2,054 1 0.05 288 18.52 0.1501
2016-07-15 2014-06-30 13F Amgen COM 031162100 2,053 2 0.10 243 -3.95 0.1341
2016-08-09 2014-03-31 13F Amgen COM 031162100 2,051 1 0.05 253 8.12 0.1762
2016-08-24 2013-12-31 13F Amgen COM 031162100 2,050 2,050 234 0.1573
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.